“…Thus far, nine different mammalian chloride channels (CLC), including CLC-K1, CLC-K2, and CLC-1 to CLC-7, have been identified (1, 4, 15, 16, 18, 19, 30, 36 -38, 40). Mutations of different chloride channels have been linked to a range of clinical conditions including CLC-1 in myotonia congenita, CLCNKB (human gene for CLC-K2) in Bartter's syndrome, and CLC-5 in Dent's disease, X-linked recessive nephrolithiasis (XLRN), X-linked recessive hypophosphatemic rickets, and low-molecular-weight (LMW) proteinuria/nephrocalcinosis (21,26,28,34,38). Clinical features reported among patients afflicted with various inactivating CLC-5 mutations include varying degrees of LMW proteinuria, hypercalciuria, hyperphosphaturia, nephrocalcinosis, nephrolithiasis, urinary concentrating defect, and renal failure.…”